Why is Kewaunee Scientific Corp. ?
1
Company has a low Debt to Equity ratio (avg) at times
2
Low Debt Company with Strong Long Term Fundamental Strength
3
The company has declared negative results in Jan'2025 after 9 consecutive positive quarters
- INTEREST(HY) At USD 2.12 MM has Grown at 131.84%
- NET PROFIT(Q) At USD 2.44 MM has Fallen at -20.52%
4
With ROE of 17.22%, it has a attractive valuation with a 1.43 Price to Book Value
- Over the past year, while the stock has generated a return of -31.37%, its profits have fallen by -36.6%
5
High Institutional Holdings at 49.14%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.6% over the previous quarter.
6
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 14.90% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -31.37% returns
How much should you hold?
- Overall Portfolio exposure to Kewaunee Scientific Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Kewaunee Scientific Corp. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Kewaunee Scientific Corp.
-30.51%
-0.28
60.74%
S&P 500
14.9%
0.77
19.29%
Quality key factors
Factor
Value
Sales Growth (5y)
14.69%
EBIT Growth (5y)
56.16%
EBIT to Interest (avg)
2.99
Debt to EBITDA (avg)
0.57
Net Debt to Equity (avg)
0.39
Sales to Capital Employed (avg)
3.20
Tax Ratio
21.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
49.14%
ROCE (avg)
18.08%
ROE (avg)
11.29%
Valuation Key Factors 
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
1.43
EV to EBIT
6.40
EV to EBITDA
4.85
EV to Capital Employed
1.31
EV to Sales
0.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
20.46%
ROE (Latest)
17.22%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
6What is working for the Company
NET SALES(HY)
At USD 141.2 MM has Grown at 46.84%
INVENTORY TURNOVER RATIO(HY)
Highest at 7.48 times
DEBTORS TURNOVER RATIO(HY)
Highest at 5.66 times
-13What is not working for the Company
INTEREST(HY)
At USD 2.12 MM has Grown at 131.84%
NET PROFIT(Q)
At USD 2.44 MM has Fallen at -20.52%
Here's what is working for Kewaunee Scientific Corp.
Net Sales
At USD 141.2 MM has Grown at 46.84%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Inventory Turnover Ratio
Highest at 7.48 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 5.66 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at USD 1.58 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Kewaunee Scientific Corp.
Interest
At USD 2.12 MM has Grown at 131.84%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Net Profit
At USD 2.44 MM has Fallen at -20.52%
over average net sales of the previous four periods of USD 3.08 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)






